Report cover image

China Turner Syndrome Market Research Report by Type (Growth Hormone Therapy, Estrogen Replacement Therapy, Progestogen Add-on Therapy, Others), by Age Group (Pediatric, Adult), by Route of Administration (Oral, Parenteral, Others), and by Distribution Ch

Publisher Market Research Future
Published Aug 08, 2026
Length 104 Pages
SKU # RESFT21548057

Description

The China Turner Syndrome Market is estimated at USD 157.89 million in 2025 and is expected to reach USD 323.11 million by 2035. This growth represents a CAGR of 6.92% over the forecast period, reflecting rising demand for effective Turner syndrome management.

Affordable Growth Hormone Treatment
The availability of various domestically produced rhGH products, especially the long-acting formulations, is leading to increased use of growth hormone therapyу in Turner Syndrome patients in China. Besides decreasing drug cost, insurance policy coverage and procurement of medicines by government, they all add to the increased number of Turner Syndrome patients getting access to growth hormone treatments.

Industry Segmentations Highlights
By Type
• Growth Hormone Therapy: Drives growth and height improvement.
• Estrogen Replacement Therapy: Supports normal female sexual development.
• Progestogen Add-on Therapy: Complements estrogen for reproductive health.
• Others: Cover supportive treatments for associated conditions.
By Age Group
• Pediatric: Dominates treatment during childhood and adolescence.
• Adult: Requires continued monitoring and hormone management.
By Route of Administration
• Oral: Provides convenient options for hormone replacement.
• Parenteral: Commonly used for injectable therapeutic treatments.
• Others: Offer alternative treatment administration options.
By Distribution Channel
• Hospital Pharmacies: Serve patients requiring specialized medical treatment.
• Retail Pharmacies: Offer accessible medication purchasing options.
• Online Pharmacies: Expand convenient access to prescribed medicines.

Launch of Pegpesen Strengthens Pediatric Growth Therapy
Amoy top Biotech released Pegpesen into the Chinese market on June 23, 2025, offering the option of once-weekly pediatric growth hormoneе deficiency therapy treatment. Its reduced dosing frequency provides greater convenience for children and families undergoing long-term growth hormone therapy.

Expanding Fertility Preservation Pathways
Increasing emphasis on fertility planning is enabling the China Turner Syndrome Market to address quality-of-life needs across the patient journey, particularly as more women transition into adulthood. Growing access to fertility services and medical insurance support is helping reduce financial barriers while encouraging earlier preservation interventions.

Key Report Attributes
• Market Size 2025: USD 157.89 Million
• Market Size 2035: USD 323.11 Million
• CAGR (2025-2035): 6.92%
• Base Year: 2024
• Market Forecast Period: 2025-2035

Industry Segmentations Growth
• By Type: Growth Hormone Therapy - 7.48%, Estrogen Replacement Therapy - 6.62%.
• By Age Group: Pediatric - 6.58%, Adult - 7.39%.
• By Route of Administration: Oral - 7.70%, Parenteral - 6.83%.
• By Distribution Channel: Hospital Pharmacies - 6.56%, Retail Pharmacies - 7.23%.

Table of Contents

104 Pages
1 Executive Summary
2 Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.3 Research Objective
2.4 Market Structure
3 Research Methodology
3.1 Overview
3.2 Data Flow
3.2.1 Data Mining Process
3.3 Purchased Database:
3.4 Secondary Sources:
3.4.1 Secondary Research Data Flow:
3.5 Primary Research:
3.5.1 Primary Research Data Flow:
3.5.2 Primary Research: Number Of Interviews Conducted
3.6 Approaches For Market Size Estimation:
3.6.1 Revenue Analysis Approach
3.7 Data Forecasting
3.7.1 Data Forecasting Type
3.8 Data Modeling
3.8.1 Microeconomic Factor Analysis:
3.8.2 Data Modeling:
3.9 Teams And Analyst Contribution
4 Market Dynamics
4.1 Introduction
4.2 Drivers
4.2.1 Surge In Pediatric Diagnosis Rates
4.2.2 Growth Hormone (Gh) Accessibility
4.2.3 Expansion Of Hospital-based Specialist Care
4.2.4 Increasing Awareness Of Adult Transitions
4.3 Restraints
4.3.1 High Lifelong Treatment Costs
4.3.2 Parenteral Administration Barriers
4.3.3 Underdiagnosis In Adult Populations
4.4 Opportunities
4.4.1 Shift To Long-acting Formulations
4.4.2 Fertility-focused Adult Care
5 Market Factor Analysis
5.1 Regulatory Environment & Compliance
5.2 Market Trends & Innovation
5.3 Patient Demographics & Disease Burdens
5.4 Market Entry & Exit Barriers
5.4.1 Barriers To Entry
5.4.2 Barriers To Exit
5.5 Partnerships & Collaborations
5.6 Pricing Analysis
5.6.1 Pricing Analysis
5.6.1.1 China
5.6.1.1.1 China Pricing Analysis, By Product
5.7 Consumer & Healthcare Provider Preferences
5.7.1 Consumer Preferences
5.7.2 Healthcare Provider Preferences
5.8 Pestle Analysis
5.8.1 Political Factors
5.8.2 Economic Factors
5.8.3 Social Factors
5.8.4 Technological Factors
5.8.5 Legal Factors
5.8.6 Environmental Factors
5.9 Case Study Analysis
5.10 Investment & Funding Scenarios
5.11 Post-market Surveillance & Safety Data
6 China Turner Syndrome Market, By Type
6.1 Overview
7 China Turner Syndrome Market, By Age Group
7.1 Overview
8 China Turner Syndrome Market, By Route Of Administration
8.1 Overview
9 China Turner Syndrome Market, By Distribution Channel
9.1 Overview
10 Competitive Landscape
10.1 Introduction
10.2 Market Share Analysis, 2025
10.3 Competitor Dashboard
10.4 Public Players Stock Summary
10.5 Comparative Analysis: Key Players Financial
10.6 Key Developments & Growth Strategies
10.6.1 Product Approval
10.6.2 Product Launch
11 Company Profiles
11.1 Merck Kgaa
11.1.1 Company Overview
11.1.2 Financial Overview
11.1.3 Products/Services Offered
11.1.4 Key Developments
11.1.5 Swot Analysis
11.1.6 Key Strategies
11.2 Ferring Pharmaceuticals
11.2.1 Company Overview
11.2.2 Financial Overview
11.2.3 Products Offered
11.2.4 Key Developments
11.2.5 Key Strategies
11.3 Lg Chem.
11.3.1 Company Overview
11.3.2 Financial Overview
11.3.3 Products Offered
11.3.4 Key Developments
11.3.5 Swot Analysis
11.3.6 Key Strategies
11.4 Anke Bio Co., Ltd
11.4.1 Company Overview
11.4.2 Financial Overview
11.4.3 Products Offered
11.4.4 Key Developments
11.4.5 Swot Analysis
11.4.6 Key Strategy
11.5 Amoy Top Biotech
11.5.1 Company Overview
11.5.2 Financial Overview
11.5.3 Products Offered
11.5.4 Key Developments
11.5.5 Key Strategies
11.6 Pfizer Inc.
11.6.1 Company Overview
11.6.2 Financial Overview
11.6.3 Products Offered
11.6.4 Key Developments
11.6.5 Swot Analysis
11.6.6 Key Strategies
11.7 Eli Lilly And Company
11.7.1 Company Overview
11.7.2 Financial Overview
11.7.3 Products Offered
11.7.4 Key Developments
11.7.5 Swot Analysis
11.7.6 Key Strategies
11.8 Novo Nordisk A/S
11.8.1 Company Overview
11.8.2 Financial Overview
11.8.3 Products Offered
11.8.4 Key Developments
11.8.5 Key Strategies
11.9 Changchun Gene Science Pharmaceutical Co., Ltd.
11.9.1 Company Overview
11.9.2 Financial Overview
11.9.3 Products Offered
11.9.4 Key Developments
11.9.5 Key Strategies
11.10 San Sure Hygiene Biomedicine Co., Ltd.
11.10.1 Company Overview
11.10.2 Financial Overview
11.10.3 Products Offered
11.10.4 Key Developments
11.10.5 Key Strategies
12 Data Citations
List Of Tables
Table 1 Qfd Modeling For Market Share Assessment
Table 2 China Turner Syndrome Market, By Type, 2019-2036 (Usd Million)
Table 3 China Turner Syndrome Market, By Age Group, 2019-2036 (Usd Million)
Table 4 China Turner Syndrome Market, By Route Of Administration, 2019-2036 (Usd Million)
Table 5 China Turner Syndrome Market Share (%), By Route Of Administration, 2025
Table 6 China Turner Syndrome Market, By Distribution Channel, 2019-2036 (Usd Million)
Table 7 China Turner Syndrome Market Share (%), By Distribution Channel, 2025
Table 8 Product Approval
Table 9 Product Launch
Table 10 Merck Kgaa: Products Offering
Table 11 Ferring Pharmaceuticals: Products Offered
Table 12 Lg Chem.: Product Offered
Table 13 Ankebio Co., Ltd: Products Offered
Table 14 Amoytop Biotech: Products Offered
Table 15 Amoytop Biotech: Key Developments
Table 16 Pfizer Inc.: Products Offered
Table 17 Eli Lilly And Company: Products Offered
Table 18 Novo Nordisk A/S: Products Offered
Table 19 Changchun Genescience Pharmaceutical Co., Ltd.: Products Offered
Table 20 Changchun Genescience Pharmaceutical Co., Ltd.: Key Developments
Table 21 Zhongshan Sansure Hygene Biomedicine Co., Ltd.: Products Offered
List Of Figures
Figure 1 China Turner Syndrome Market : Structure
Figure 1 China Turner Syndrome Market: Market Growth Affecting Factor Analysis (2019-2036)
Figure 2 China Turner Syndrome Market Driver: Impact Analysis
Figure 3 China Turner Syndrome Market Restraint: Impact Analysis
Figure 4 China Turner Syndrome Market, Type Segment Attractiveness, 2025 & 2036 (Usd Million)
Figure 5 China Turner Syndrome Market, By Type, 2025 & 2036 (Usd Million)
Figure 6 China Turner Syndrome Market Share (%), By Type, 2025
Figure 7 China Turner Syndrome Market, Age Group Segment Attractiveness, 2025 & 2036 (Usd Million)
Figure 8 China Turner Syndrome Market, By Age Group, 2025 & 2036 (Usd Million)
Figure 9 China Turner Syndrome Market Share (%), By Age Group, 2025
Figure 10 China Turner Syndrome Market, Route Of Administration Segment Attractiveness, 2025 & 2036 (Usd Million)
Figure 11 China Turner Syndrome Market, By Route Of Administration, 2025 & 2036 (Usd Million)
Figure 12 China Turner Syndrome Market, Distribution Channel Segment Attractiveness, 2025 & 2036 (Usd Million)
Figure 13 China Turner Syndrome Market, By Distribution Channel, 2025 & 2036 (Usd Million)
Figure 14 China Turner Syndrome Market Players: Competitive Analysis, 2025
Figure 15 Competitor Dashboard: China Turner Syndrome Market
Figure 16 Merck Kgaa: Financial Overview Snapshot
Figure 17 Merck Kgga: Swot Analysis
Figure 18 Ferring Pharmaceuticals: Financial Overview Snapshot
Figure 19 Lg Chem.: Financial Overview Snapshot
Figure 20 Lg Chem.: Swot Analysis
Figure 21 Ankebio Co., Ltd: Swot Analysis
Figure 22 Pfizer Inc.: Financial Overview Snapshot
Figure 23 Pfizer Inc.: Swot Analysis
Figure 24 Eli Lilly And Company: Financial Overview Snapshot
Figure 25 Eli Lilly And Company: Swot Analysis
Figure 26 Novo Nordisk A/S: Financial Overview Snapshot

Search Inside Report

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us